| Healthcare use after screening for lung cancer. | |
| | |
MedLine Citation:
|
PMID: 20597136 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: To evaluate the benefits of lung cancer screening, all effects of screening need to be considered. The aim of this study was to determine whether screening had an effect on healthcare use, specifically whether use increased for those with a false-positive or indeterminate screening result. METHODS: Recruited were 400 individuals participating in a lung cancer screening study at the University of Pittsburgh. Self-reported outpatient healthcare use information was collected for the 6 months before, 0 to 6 months after, and 6 to 12 months after screening. The screening outcomes were negative, indeterminate, and suspicious. Repeated-measures Poisson regression models were used to examine changes in use over time and how changes over time varied among the screening outcome groups. RESULTS: Approximately 58% of participants had a negative screening result, 36% had an indeterminate result, and approximately 6% had a suspicious result. The percentage of individuals who had any incidence of each type of outpatient use increased after screening, with the greatest increase noted for those with a suspicious screening result. Adjusted mean use significantly increased for nearly all types of use and for all 3 screening results categories in the 6 months after screening, but mostly declined to prescreening levels in the next 6 months. CONCLUSIONS: Outpatient healthcare use was found to increase after screening for all individuals who were screened for lung cancer, regardless of the screening finding. The cost of the lung-related visits alone was substantial. Therefore, if lung cancer screening prevalence is increased, attendant follow-up healthcare costs are also likely to increase. |
| | |
Authors:
|
Margaret M Byrne; Tulay Koru-Sengul; Wei Zhao; Joel L Weissfeld; Mark S Roberts |
Related Documents
:
|
10388176 - Population-based mammographic screening: does 'informed choice' require any less than f... 17925086 - Improved survival rate for women with interval breast cancer - results from the breast ... 12187166 - Measuring breast, colorectal, and prostate cancer screening with medicare claims data. 19154476 - The haphazard approach to the early detection of asymptomatic renal cancer: results fro... 22574746 - Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in pat... 9951876 - Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated w... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural |
Journal Detail:
|
Title: Cancer Volume: 116 ISSN: 0008-543X ISO Abbreviation: Cancer Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-10-06 Completed Date: 2010-11-16 Revised Date: 2013-05-14 |
Medline Journal Info:
|
Nlm Unique ID: 0374236 Medline TA: Cancer Country: United States |
Other Details:
|
Languages: eng Pagination: 4793-9 Citation Subset: AIM; IM |
Copyright Information:
|
© 2010 American Cancer Society. |
Affiliation:
|
Department of Epidemiology and Public Health, University of Miami Miller School of Medicine, Miami, Florida 33136, USA. mbyrne2@med.miami.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Early Detection of Cancer False Positive Reactions Female Humans Lung Neoplasms / diagnosis, economics*, psychology Male Mass Screening / economics* Middle Aged Patient Acceptance of Health Care / statistics & numerical data* Tomography, Spiral Computed |
| Grant Support | |
ID/Acronym/Agency:
|
K07 CA10181/CA/NCI NIH HHS; K07 CA101812/CA/NCI NIH HHS |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ohio Appalachian women's perceptions of the cost of cervical cancer screening.
Next Document: Development of curcumin as an epigenetic agent.